13302 Federal Register / Vol. 87, No. 46 / Wednesday, March 9, 2022 / Notices 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; Review of Neurosurgeon 

K12 Applications. 

Date: April 5, 2022. 

Time: 4:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: William C. Benzing, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS, NIH, NSC, 6001 Executive 

Boulevard, Suite 3204, MSC 9529, Bethesda, 

MD 20892–9529, 301–496–0660, benzingw@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: March 3, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–04943 Filed 3–8–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Sleep Disorders Research 

Advisory Board. The meeting will be 

open to the public, with attendance 

limited to space available. Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

Name of Committee: Sleep Disorders 

Research Advisory Board. 

Date: April 7, 2022. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: The purpose of this meeting is to 

update the Advisory Board and public 

stakeholders on the progress of sleep and 

circadian research activities across NIH, and 

the activities of Federal stakeholders and 

professional societies. 

Place: Virtual Meeting. 

Telephone Access: 1–666–254–5252 

(Meeting ID: 161 532 8417 Passcode: 330488). 

Virtual Access: https://nih.zoomgov.com/s/ 

1615328417?pwd=Wm52ZmZFMDVa

RWE4bGVsOTcrSW1UUT09. 

Contact Person: Marishka Brown, BS, MS, 

Ph.D., Health Scientist Administrator, 

National Center on Sleep Disorders Research, 

National Heart, Lung, and Blood Institute, 

National Institute of Health, 6705 Rockledge 

Drive, Bethesda 20814–7952, 301–435–0199, 

ncsdr@nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. Information is also 

available on the Institute’s/Center’s home 

page: www.nhlbi.nih.gov/meetings/ 

index.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: March 4, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–04982 Filed 3–8–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Promoting Bunyavirales 

Basic Science Research (R01 Clinical Trial 

Not Allowed). 

Date: April 5–6, 2022. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E72A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Frank S. De Silva, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3E72A, Rockville, MD 

20852, (240) 669–5023, fdesilva@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: March 3, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–04942 Filed 3–8–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Treatment 

(CSAT) National Advisory Council 

(NAC) will meet on April 27, 2022, 1:00 

p.m.–4:30 p.m. (EDT). 

The meeting is open to the public and 

will include consideration of minutes 

from the SAMHSA CSAT NAC meeting 

of August 12, 2021, and a discussion 

with SAMHSA leadership. It will also 

cover updates on CSAT activities from 

the Office of the Director (OD); the 

Division of Pharmacologic Therapies 

(DPT); the State Opioid Response 

Program (SOR); the Division of State 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 46 / Wednesday, March 9, 2022 / Notices 13303 

and Community Assistance (DSCA); the 

Division of Services Improvement (DSI), 

and a discussion on substance use 

disorder and oral health. 

The meeting will be conducted via 

Zoom and telephone only and 

registration is required to participate. 

Interested persons may present data, 

information, or views, orally or in 

writing, on issues pending before the 

Council. Presentations from the public 

will be scheduled at the conclusion of 

the meeting. Individuals interested in 

making oral presentations must notify 

the contact person, Tracy Goss, CSAT 

NAC Designated Federal Officer (DFO) 

on or before April 15, 2022. Up to three 

minutes will be allotted for each 

approved public comment as time 

permits. Written comments received in 

advance of the meeting will be 

considered for inclusion in the official 

record. 

To attend virtually, submit written or 

brief oral comments, or request special 

accommodation for persons with 

disabilities, please register on-line at 

https://snacregister.samhsa.gov/ 

MeetingList.aspx, or communicate with 

the CSAT NAC DFO (see information 

below). 

Meeting information and a roster of 

Council members may be obtained by 

accessing the SAMHSA Committee 

website at https://www.samhsa.gov/ 

about-us/advisory-councils/csatnational-advisory-council, or by 

contacting the DFO. 

Council Name: SAMHSA’s Center for 

Substance Abuse Treatment, National 

Advisory Council 

Date/Time/Type: April 27, 2022, 1:00 

p.m.–4:30 p.m. EDT, Open 

Place: SAMHSA, 5600 Fishers Lane, 

Rockville, Maryland 20857 

Contact: Tracy Goss, Designated Federal 

Officer, CSAT National Advisory 

Council, 5600 Fishers Lane, Rockville, 

Maryland 20857 (mail), Telephone: 

(240) 276–0759, Email: tracy.goss@

samhsa.hhs.gov 

Dated: March 2, 2022. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2022–04910 Filed 3–8–22; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[1651–0092] 

Application for Withdrawal of Bonded 

Stores for Fishing Vessels and 

Certificate of Use (CBP Form 5125) 

AGENCY: U.S. Customs and Border 

Protection (CBP), Department of 

Homeland Security. 

ACTION: 60-Day notice and request for 

comments; extension of an existing 

collection of information. 

SUMMARY: The Department of Homeland 

Security, U.S. Customs and Border 

Protection will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995 (PRA). The 

information collection is published in 

the Federal Register to obtain comments 

from the public and affected agencies. 

DATES: Comments are encouraged and 

must be submitted (no later than May 9, 

2022) to be assured of consideration. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice must include 

the OMB Control Number 1651–0092 in 

the subject line and the agency name. 

Please use the following method to 

submit comments: 

Email. Submit comments to: CBP_

PRA@cbp.dhs.gov. 

Due to COVID–19-related restrictions, 

CBP has temporarily suspended its 

ability to receive public comments by 

mail. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional PRA information 

should be directed to Seth Renkema, 

Chief, Economic Impact Analysis 

Branch, U.S. Customs and Border 

Protection, Office of Trade, Regulations 

and Rulings, 90 K Street NE, 10th Floor, 

Washington, DC 20229–1177, telephone 

number 202–325–0056 or via email 

CBP_PRA@cbp.dhs.gov. Please note that 

the contact information provided here is 

solely for questions regarding this 

notice. Individuals seeking information 

about other CBP programs should 

contact the CBP National Customer 

Service Center at 877–227–5511, (TTY) 

1–800–877–8339, or the CBP website at 

https://www.cbp.gov/. 

SUPPLEMENTARY INFORMATION: CBP 

invites the general public and other 

Federal agencies to comment on the 

proposed and/or continuing information 

collections pursuant to the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501 

et seq.). This process is conducted in 

accordance with 5 CFR 1320.8. Written 

comments and suggestions from the 

public and affected agencies should 

address one or more of the following 

four points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; (2) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

suggestions to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) suggestions to 

minimize the burden of the collection of 

information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submission of responses. The 

comments that are submitted will be 

summarized and included in the request 

for approval. All comments will become 

a matter of public record. 

Overview of This Information 

Collection 

Title: Application for Withdrawal of 

Bonded Stores for Fishing Vessels and 

Certificate of Use. 

OMB Number: 1651–0092. 

Form Number: CBP Form 5125. 

Current Actions: Extension without 

change of an existing information 

collection. 

Type of Review: Extension (without 

change). 

Affected Public: Carriers. 

Abstract: CBP Form 5125, Application 

for Withdrawal of Bonded Stores for 

Fishing Vessel and Certificate of Use, is 

used to request the permission of the 

CBP port director for the withdrawal 

and lading of bonded merchandise 

(especially alcoholic beverages) for use 

on board fishing vessels involved in 

international trade. The applicant must 

certify on CBP Form 5125 that supplies 

on board were either consumed, or that 

all unused quantities remain on board 

and are adequately secured for use on 

the next voyage. CBP uses this form to 

collect information such as the name 

and identification number of the vessel, 

ports of departure and destination, and 

information about the crew members. 

The information collected on this form 

is authorized by 19 U.S.C. 1309 and 

1317 and is provided for by 19 CFR 

10.59(e) and 10.65. CBP Form 5125 is 

accessible at: https://www.cbp.gov/ 

newsroom/publications/ 

forms?title=5125. 


jspears on DSK121TN23PROD with NOTICES1